Editas Medicine (EDIT) Other Working Capital Changes (2017 - 2025)

Editas Medicine (EDIT) has reported Other Working Capital Changes for 9 consecutive years, with -$1.5 million the latest figure, recorded in Q3 2025.

• In Q3 2025, Other Working Capital Changes fell 606.19% year-over-year to -$1.5 million; the TTM figure through Sep 2025 stood at -$20.9 million (down 640.26% YoY), while the FY2024 annual figure was -$8.5 million, down 14.21% from the prior year.
• Other Working Capital Changes rose to -$1.5 million in Q3 2025 per EDIT's latest filing, from -$4.8 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $4.1 million in Q3 2021 and bottomed at -$4.6 million in Q1 2021.
• Historically, Other Working Capital Changes has averaged -$419368.4 across 5 years, with a median of -$160000.0 in 2023.
• On a YoY basis, Other Working Capital Changes climbed as much as 9395.83% in 2024 and fell as far as 641.04% in 2024.
• Editas Medicine's Other Working Capital Changes stood at -$11.3 million in 2021, then soared by 299.81% to $22.6 million in 2022, then sank by 91.5% to $1.9 million in 2023, then sank by 641.04% to -$10.4 million in 2024, then jumped by 85.76% to -$1.5 million in 2025.
• Business Quant data shows EDIT's Other Working Capital Changes at -$1.5 million in Q3 2025, -$4.8 million in Q2 2025, and -$4.2 million in Q1 2025.